A recent study explored whether interrupting disease-modifying therapies (DMTs) because of pregnancy leads to increased levels of a specific biomarker of neuroaxonal injury seen in MS. Pregnant women ...

Scientists have identified two previously unknown biological subtypes of multiple sclerosis (MS) using artificial ...

As levels of disability increased among patients with multiple sclerosis (MS), cost of illness increased and health-related quality of life decreased. Patients with multiple sclerosis (MS) incur ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease progression that could help identify patients most likely to benefit from new drugs.

A controversial topic in multiple sclerosis (MS) led to a recent study aiming to predict future disease activity. The investigators of a Spanish study evaluated whether serum neurofilament light chain ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window STOCKHOLM -- ...

Siemens Healthineers has inked what it describes as a “master collaboration agreement” with Novartis to help provide diagnostic tests linked to therapies across the drugmaker’s pipeline. To start, the ...

New Assay Evaluates Neutralizing Anti-IFN-β in Individuals Afflicted with Multiple Sclerosis Groundbreaking news concerning multiple sclerosis (MS) appeared in the mainstream media earlier this year ...

Air pollution may be another environmental risk factor for developing multiple sclerosis (MS), new research suggests. A large cohort study of almost 550,000 individuals living in Italy showed that ...